SLC22A12 and cancer: Furthermore, IHC results from cancer/para-cancer pairs (Figures 5G and S2) suggest that SLC22A12 was primarily located in the plasma membranes of both cancer and normal renal tubular epithelial cells; however, it was down-regulated in cancer cells.